These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1024 related items for PubMed ID: 12202501

  • 1. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 2. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA.
    Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779
    [Abstract] [Full Text] [Related]

  • 3. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P, Zaravinos A, Zioga M, Spandidos DA.
    Br J Dermatol; 2009 Jun 08; 160(6):1215-21. PubMed ID: 19298278
    [Abstract] [Full Text] [Related]

  • 4. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A.
    Virchows Arch; 2002 Aug 08; 441(2):133-42. PubMed ID: 12189502
    [Abstract] [Full Text] [Related]

  • 5. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 6. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
    Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K.
    Pathol Int; 2004 Aug 25; 54(8):549-55. PubMed ID: 15260845
    [Abstract] [Full Text] [Related]

  • 7. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T.
    Hum Pathol; 2009 Jun 25; 40(6):817-26. PubMed ID: 19200577
    [Abstract] [Full Text] [Related]

  • 8. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 9. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
    Merbs SL, Sidransky D.
    Invest Ophthalmol Vis Sci; 1999 Mar 20; 40(3):779-83. PubMed ID: 10067984
    [Abstract] [Full Text] [Related]

  • 10. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A, Langhanki L, Schütz A, Wittekind C, Bootz F, Tannapfel A.
    J Pathol; 2002 Nov 20; 198(3):326-34. PubMed ID: 12375265
    [Abstract] [Full Text] [Related]

  • 11. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
    Tannapfel A, Sommerer F, Benicke M, Weinans L, Katalinic A, Geissler F, Uhlmann D, Hauss J, Wittekind C.
    J Pathol; 2002 Aug 20; 197(5):624-31. PubMed ID: 12210082
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma.
    Hearle N, Damato BE, Humphreys J, Wixey J, Green H, Stone J, Easton DF, Houlston RS.
    Invest Ophthalmol Vis Sci; 2003 Feb 20; 44(2):458-62. PubMed ID: 12556369
    [Abstract] [Full Text] [Related]

  • 14. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J, Fried M.
    Oncogene; 2001 Nov 01; 20(50):7447-52. PubMed ID: 11704876
    [Abstract] [Full Text] [Related]

  • 15. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K, Enokida H, Gotanda T, Kubo H, Nishiyama K, Kawahara M, Nakagawa M.
    Biochem Biophys Res Commun; 2006 Jan 20; 339(3):790-6. PubMed ID: 16316628
    [Abstract] [Full Text] [Related]

  • 16. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 20; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 17. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L, Eymin B, Brambilla E, Gazzeri S.
    Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784
    [Abstract] [Full Text] [Related]

  • 18. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G.
    Hepatology; 2002 Aug 04; 36(2):427-32. PubMed ID: 12143052
    [Abstract] [Full Text] [Related]

  • 19. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G, Scheubner M, Zimmermann Y, Kalla J, Katzenberger T, Hübler K, Roth S, Hiddemann W, Ott G, Dreyling M.
    Genes Chromosomes Cancer; 2006 Feb 04; 45(2):203-10. PubMed ID: 16258956
    [Abstract] [Full Text] [Related]

  • 20. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.
    Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, Weghorst CM.
    Cancer Res; 2002 Sep 15; 62(18):5295-300. PubMed ID: 12234999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.